Last updated on February 2020

AGN-241751 in the Treatment of Major Depressive Disorder

Brief description of study

To evaluate the efficacy at 1 day post initial oral dose of AGN-241751 compared with placebo in participants with MDD

Clinical Study Identifier: NCT03586427

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.